{"owner": "ArrayExpress Uploader", "pop_total": 0, "id": 3673, "factors": [{"GSM44592": {"PATIENT ID": 2, "COHORT": "Validation", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445922": {"PATIENT ID": 3, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "wild type"}}, {"GSM445923": {"PATIENT ID": 4, "COHORT": "Discovery", "KARYOTYPE": "t(15;17)", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM445925": {"PATIENT ID": 6, "COHORT": "Validation", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM445926": {"PATIENT ID": 7, "COHORT": "Validation", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445927": {"PATIENT ID": 8, "COHORT": "Discovery", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "N/K-RAS mutant; FLT3-ITD mutant"}}, {"GSM445928": {"PATIENT ID": 9, "COHORT": "Validation", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM445929": {"PATIENT ID": 10, "COHORT": "Discovery", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "wild type"}}, {"GSM445930": {"PATIENT ID": 11, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "NPM1 mutant"}}, {"GSM44593": {"PATIENT ID": 12, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445932": {"PATIENT ID": 13, "COHORT": "Validation", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "PTPN11 mutant"}}, {"GSM445933": {"PATIENT ID": 14, "COHORT": "Validation", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "NPM1 mutant; FLT3 mutant"}}, {"GSM445934": {"PATIENT ID": 15, "COHORT": "Validation", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "CEBPA mutant"}}, {"GSM445935": {"PATIENT ID": 16, "COHORT": "Validation", "KARYOTYPE": "t(8;21)", "GENOTYPE": "C-KIT mutant"}}, {"GSM445936": {"PATIENT ID": 17, "COHORT": "Validation", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445937": {"PATIENT ID": 18, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "NPM1 mutant; FLT3-ITD mutant"}}, {"GSM445938": {"PATIENT ID": 19, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445939": {"PATIENT ID": 20, "COHORT": "Discovery", "KARYOTYPE": "inv(16)", "GENOTYPE": "C-KIT mutant"}}, {"GSM445940": {"PATIENT ID": 21, "COHORT": "Discovery", "KARYOTYPE": "inv(16)", "GENOTYPE": "C-KIT mutant"}}, {"GSM44594": {"PATIENT ID": 22, "COHORT": "Validation", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445942": {"PATIENT ID": 23, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445943": {"PATIENT ID": 24, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "wild type"}}, {"GSM445944": {"PATIENT ID": 25, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "N/K-RAS mutant; NPM1 mutant"}}, {"GSM445945": {"PATIENT ID": 26, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "CEBPA mutant"}}, {"GSM445946": {"PATIENT ID": 27, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445947": {"PATIENT ID": 28, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445948": {"PATIENT ID": 29, "COHORT": "Validation", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM445950": {"PATIENT ID": 31, "COHORT": "Validation", "KARYOTYPE": "t(8;21)", "GENOTYPE": "C-KIT mutant"}}, {"GSM44595": {"PATIENT ID": 32, "COHORT": "Discovery", "KARYOTYPE": "t(7;12)", "GENOTYPE": "wild type"}}, {"GSM445952": {"PATIENT ID": 33, "COHORT": "Validation", "KARYOTYPE": "inv(16)", "GENOTYPE": "wild type"}}, {"GSM445953": {"PATIENT ID": 34, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM445954": {"PATIENT ID": 35, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445959": {"PATIENT ID": 40, "COHORT": "Validation", "KARYOTYPE": "t(8;21)", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM445963": {"PATIENT ID": 44, "COHORT": "Validation", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445964": {"PATIENT ID": 45, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "C-KIT mutant"}}, {"GSM445965": {"PATIENT ID": 46, "COHORT": "Discovery", "KARYOTYPE": "inv(16)", "GENOTYPE": "C-KIT mutant"}}, {"GSM445966": {"PATIENT ID": 47, "COHORT": "Validation", "KARYOTYPE": "inv(16)", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445967": {"PATIENT ID": 48, "COHORT": "Validation", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM445968": {"PATIENT ID": 49, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445969": {"PATIENT ID": 50, "COHORT": "Validation", "KARYOTYPE": "CN-AML", "GENOTYPE": "NPM1 mutant; FLT3-ITD mutant"}}, {"GSM445970": {"PATIENT ID": 51, "COHORT": "Validation", "KARYOTYPE": "t(8;21)", "GENOTYPE": "C-KIT mutant"}}, {"GSM44597": {"PATIENT ID": 52, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM445972": {"PATIENT ID": 53, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "wild type"}}, {"GSM445973": {"PATIENT ID": 54, "COHORT": "Validation", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "CEBPA mutant"}}, {"GSM445974": {"PATIENT ID": 55, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM445975": {"PATIENT ID": 56, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM445976": {"PATIENT ID": 57, "COHORT": "Validation", "KARYOTYPE": "CN-AML", "GENOTYPE": "MLL-PTD mutant"}}, {"GSM445977": {"PATIENT ID": 58, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445978": {"PATIENT ID": 59, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM445979": {"PATIENT ID": 60, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445980": {"PATIENT ID": 61, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM445985": {"PATIENT ID": 66, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "MLL-PTD mutant; N/K-RAS mutant"}}, {"GSM44604": {"PATIENT ID": 122, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446042": {"PATIENT ID": 123, "COHORT": "Validation", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446043": {"PATIENT ID": 124, "COHORT": "Validation", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM446044": {"PATIENT ID": 125, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446046": {"PATIENT ID": 127, "COHORT": "Validation", "KARYOTYPE": "CN-AML", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM446047": {"PATIENT ID": 128, "COHORT": "Validation", "KARYOTYPE": "inv(16)", "GENOTYPE": "C-KIT mutant"}}, {"GSM446048": {"PATIENT ID": 129, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM446049": {"PATIENT ID": 130, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "N/K-RAS mutant; NPM1 mutant"}}, {"GSM446050": {"PATIENT ID": 131, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "N/K-RAS mutant; FLT3-ITD mutant"}}, {"GSM44605": {"PATIENT ID": 132, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM446052": {"PATIENT ID": 133, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM446053": {"PATIENT ID": 134, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446054": {"PATIENT ID": 135, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "wild type"}}, {"GSM446055": {"PATIENT ID": 136, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "wild type"}}, {"GSM446056": {"PATIENT ID": 137, "COHORT": "Discovery", "KARYOTYPE": "inv(16)", "GENOTYPE": "wild type"}}, {"GSM446057": {"PATIENT ID": 138, "COHORT": "Validation", "KARYOTYPE": "t(8;21)", "GENOTYPE": "wild type"}}, {"GSM446058": {"PATIENT ID": 139, "COHORT": "Discovery", "KARYOTYPE": "t(15;17)", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM446059": {"PATIENT ID": 140, "COHORT": "Discovery", "KARYOTYPE": "t(15;17)", "GENOTYPE": "wild type"}}, {"GSM446060": {"PATIENT ID": 141, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM44606": {"PATIENT ID": 142, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446062": {"PATIENT ID": 143, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM446063": {"PATIENT ID": 144, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "CEBPA mutant"}}, {"GSM446064": {"PATIENT ID": 145, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM446065": {"PATIENT ID": 146, "COHORT": "Validation", "KARYOTYPE": "CN-AML", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM446066": {"PATIENT ID": 147, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "wild type"}}, {"GSM446067": {"PATIENT ID": 148, "COHORT": "Discovery", "KARYOTYPE": "t(8;21)", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM446068": {"PATIENT ID": 149, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "MLL-PTD mutant; FLT3-ITD mutant"}}, {"GSM446070": {"PATIENT ID": 151, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM44607": {"PATIENT ID": 152, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446072": {"PATIENT ID": 153, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "wild type"}}, {"GSM446073": {"PATIENT ID": 154, "COHORT": "Discovery", "KARYOTYPE": "CN-AML", "GENOTYPE": "FLT3-ITD mutant"}}, {"GSM446074": {"PATIENT ID": 155, "COHORT": "Validation", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "CEBPA mutant"}}, {"GSM446076": {"PATIENT ID": 157, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446077": {"PATIENT ID": 158, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446078": {"PATIENT ID": 159, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "PTPN11 mutant"}}, {"GSM446079": {"PATIENT ID": 160, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "wild type"}}, {"GSM446080": {"PATIENT ID": 161, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM44608": {"PATIENT ID": 162, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "N/K-RAS mutant"}}, {"GSM446082": {"PATIENT ID": 163, "COHORT": "Discovery", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446083": {"PATIENT ID": 164, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "CEBPA mutant; FLT3-ITD mutant"}}, {"GSM446084": {"PATIENT ID": 165, "COHORT": "Validation", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "CEBPA mutant"}}, {"GSM446085": {"PATIENT ID": 166, "COHORT": "Discovery", "KARYOTYPE": "MLL-rearrangement", "GENOTYPE": "C-KIT mutant"}}, {"GSM446086": {"PATIENT ID": 167, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}, {"GSM446087": {"PATIENT ID": 168, "COHORT": "Discovery", "KARYOTYPE": "unknown cytogenetics", "GENOTYPE": "PTPN11 mutant"}}, {"GSM446088": {"PATIENT ID": 169, "COHORT": "Discovery", "KARYOTYPE": "inv(16)", "GENOTYPE": "C-KIT mutant"}}, {"GSM446089": {"PATIENT ID": 170, "COHORT": "Discovery", "KARYOTYPE": "remaining cytogenetics", "GENOTYPE": "wild type"}}], "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "High VEGFC mRNA expression of AML blasts is related to increased in vitro and in vivo drug resistance. The prognostic significance of...", "pubmed_id": 20522712, "geo_gse_id": "E-GEOD-22056", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 4, "sample_count": 98, "tags": ["bone", "bone marrow", "peripheral"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "transcription-profiling-by-array-of-human-acute-2", "geo_id_plat": "E-GEOD-22056_A-AFFY-44", "name": "Transcription profiling by array of human acute myeloid leukemia patients", "created": "Sep.15, 2014", "summary": "High VEGFC mRNA expression of AML blasts is related to increased in vitro and in vivo drug resistance. The prognostic significance of VEGFC on long-term outcome and its associated gene expression profiles remain to be defined. We studied the effect of VEGFC on treatment outcome and investigated gene expression profiles associated with VEGFC using microarray data of 525 adult and 100 pediatric AML patients. High VEGFC expression appeared strongly associated with reduced complete remission rate, reduced overall and event-free survival (OS and EFS) in adult AML. Multivariable analysis established high VEGFC as prognostic indicator independent of cytogenetic risk, FLT3-ITD, NPM1, CEBPA, age and WBC. Also in pediatric AML high VEGFC was related to reduced OS. A unique series of differentially expressed genes was identified that distinguished AML with high VEGFC from AML with low VEGFC, i.e., 331 upregulated genes (representative of proliferation, VEGF-receptor activity, signal transduction) and 44 downregulated genes (e.g. related to apoptosis) consistent with a role in enhanced chemoresistance. In conclusion, high VEGFC predicts adverse long-term prognosis and provides prognostic information in addition to well-known prognostic factors.  98 bone marrow and peripheral blood samples were collected at diagnosis and frozen. They were later thawed and hybridized to Affymetrix U133 Plus 2.0 arrays.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22056", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22056/samples/"}